115 related articles for article (PubMed ID: 17036524)
1. The correlation between TTF-1 immunoreactivity and the occurrence of lymph node metastases in patients with lung cancer.
Altaner S; Yoruk Y; Tokatli F; Koçak Z; Tosun B; Guresci S; Kutlu K
Tumori; 2006; 92(4):323-6. PubMed ID: 17036524
[TBL] [Abstract][Full Text] [Related]
2. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
Argon A; Nart D; Veral A
Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
[TBL] [Abstract][Full Text] [Related]
3. [Thyroid transcription factor-1 in pulmonary cytology].
Smojver-Jezek S; Vrabec-Branica B; Juros Z; Boras Z; Cucević B; Mazuranić I
Acta Med Croatica; 2008 Oct; 62(4):373-8. PubMed ID: 19205414
[TBL] [Abstract][Full Text] [Related]
4. Thyroid transcription factor 1 in pulmonary adenocarcinoma.
Stenhouse G; Fyfe N; King G; Chapman A; Kerr KM
J Clin Pathol; 2004 Apr; 57(4):383-7. PubMed ID: 15047742
[TBL] [Abstract][Full Text] [Related]
5. Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.
Kadota K; Nitadori J; Rekhtman N; Jones DR; Adusumilli PS; Travis WD
Am J Surg Pathol; 2015 Sep; 39(9):1170-80. PubMed ID: 25871623
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
Srodon M; Westra WH
Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
[TBL] [Abstract][Full Text] [Related]
7. Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes.
Roh MS; Hong SH
J Korean Med Sci; 2002 Aug; 17(4):512-7. PubMed ID: 12172048
[TBL] [Abstract][Full Text] [Related]
8. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of lymph node micrometastasis at the pN₀ stage of lung adenocarcinoma using a combination of markers.
Liu H; Ye YK; Li GM; Zhou Y; Han KB; Xu G; Wang D
Genet Mol Res; 2014 Jul; 13(3):5594-600. PubMed ID: 25117316
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.
Saad RS; Liu YL; Han H; Landreneau RJ; Silverman JF
Hum Pathol; 2004 Jan; 35(1):3-7. PubMed ID: 14745718
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic value of the monoclonal antibody to thyroid transcription factor -1(TTF-1) in CNS metastases. An immunohistochemical study of 65 cases].
Romeike BF; Feiden W
Pathologe; 2002 Jul; 23(4):292-6. PubMed ID: 12185782
[TBL] [Abstract][Full Text] [Related]
12. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.
Tan D; Li Q; Deeb G; Ramnath N; Slocum HK; Brooks J; Cheney R; Wiseman S; Anderson T; Loewen G
Hum Pathol; 2003 Jun; 34(6):597-604. PubMed ID: 12827614
[TBL] [Abstract][Full Text] [Related]
13. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.
Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA
Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987
[TBL] [Abstract][Full Text] [Related]
14. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases.
Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK
Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515
[TBL] [Abstract][Full Text] [Related]
15. KRAS mutation-positive bronchial surface epithelium (BSE)-type lung adenocarcinoma with strong expression of TTF-1: a case providing a further insight as for the role of TTF-1 in the oncogenesis.
Takanashi Y; Tajima S; Hayakawa T; Neyatani H; Funai K
Int J Clin Exp Pathol; 2015; 8(11):15338-43. PubMed ID: 26823891
[TBL] [Abstract][Full Text] [Related]
16. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin.
Compérat E; Zhang F; Perrotin C; Molina T; Magdeleinat P; Marmey B; Régnard JF; Audouin J; Camilleri-Broët S
Mod Pathol; 2005 Oct; 18(10):1371-6. PubMed ID: 15861215
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of thyroid transcription factor-1 (TTF-1) in advanced and inoperable adenocarcinoma subtype of lung cancer among Thai patients.
Maneechawakajorn J; Benjawongsathien D
J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S11-7. PubMed ID: 25509690
[TBL] [Abstract][Full Text] [Related]
18. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin.
Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS
Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132
[TBL] [Abstract][Full Text] [Related]
19. Utility of thyroid transcription factor-1 expression in the differential diagnosis of metastatic adenocarcinoma of serous effusion specimens prepared using the cell transfer technique.
Jan IS; Chung PF; Weng MH; Huang MS; Lee YT; Kuo SH
J Formos Med Assoc; 2006 Sep; 105(9):695-700. PubMed ID: 16959616
[TBL] [Abstract][Full Text] [Related]
20. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
Yaman B; Nart D; Ekren PK; Çok G; Veral A
Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
